0000925421-23-000018.txt : 20230829
0000925421-23-000018.hdr.sgml : 20230829
20230829165656
ACCESSION NUMBER: 0000925421-23-000018
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230829
DATE AS OF CHANGE: 20230829
EFFECTIVENESS DATE: 20230829
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Skye Bioscience, Inc.
CENTRAL INDEX KEY: 0001516551
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450692882
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-490948
FILM NUMBER: 231222716
BUSINESS ADDRESS:
STREET 1: 11250 EL CAMINO REAL, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 410-0266
MAIL ADDRESS:
STREET 1: 11250 EL CAMINO REAL, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Emerald Bioscience, Inc.
DATE OF NAME CHANGE: 20190325
FORMER COMPANY:
FORMER CONFORMED NAME: Nemus Bioscience, Inc.
DATE OF NAME CHANGE: 20141030
FORMER COMPANY:
FORMER CONFORMED NAME: LOAD GUARD LOGISTICS, INC.
DATE OF NAME CHANGE: 20121107
D
1
primary_doc.xml
X0708
D
LIVE
0001516551
Skye Bioscience, Inc.
11250 EL CAMINO REAL, SUITE 100
SAN DIEGO
CA
CALIFORNIA
92130
(858) 410-0266
NEVADA
Load Guard Transportation, Inc.
Emerald Bioscience, Inc.
Nemus Bioscience, Inc.
LOAD GUARD LOGISTICS, INC.
Corporation
true
Punit
Dhillon
11250 El Camino Real
Suite 100
San Diego
CA
CALIFORNIA
92130
Executive Officer
Director
Chief Executive Officer, Chairman and Director
Kaitlyn
Arsenault
11250 El Camino Real
Suite 100
San Diego
CA
CALIFORNIA
92130
Executive Officer
Chief Financial Officer
Margaret
Dalesandro
11250 El Camino Real
Suite 100
San Diego
CA
CALIFORNIA
92130
Director
Deborah
Charych
11250 El Camino Real
Suite 100
San Diego
CA
CALIFORNIA
92130
Director
Praveen
Tyle
11250 El Camino Real
Suite 100
San Diego
CA
CALIFORNIA
92130
Director
Keith
Ward
11250 El Camino Real
Suite 100
San Diego
CA
CALIFORNIA
92130
Director
Andrew
Schwab
11250 El Camino Real
Suite 100
San Diego
CA
CALIFORNIA
92130
Director
Paul
Grayson
11250 El Camino Real
Suite 100
San Diego
CA
CALIFORNIA
92130
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-08-15
false
true
true
true
true
true
A portion of this offering is made pursuant to that certain Agreement and Plan of Merger and Reorganization, dated August 15, 2023, by and among Skye Bioscience, Inc., Aquila Merger Sub, Inc., and Bird Rock Bio, Inc. (the "Merger Agreement").
0
62254435
62254435
0
For a description of these transactions, see the Company's Current Report on Form 8-K, as filed with the SEC on August 21, 2023.
false
12
0
0
0
false
Skye Bioscience, Inc.
/s/ Kaitlyn Arsenault
Kaitlyn Arsenault
Chief Financial Officer
2023-08-29